CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

NVSNOVARTIS AG

NYSE · Pharmaceutical Preparations
Last close $142.57 · 2026-09-30
ABOUT
ExchangeNYSE
SectorHealthcare
IndustryPharmaceutical Preparations
INSTITUTIONAL OWNERSHIP
Institutional holders1,763
Shares held142,646,202
Value$21.36B
Percent of shares outstanding7.48%
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2026-03-31 · Alan Armstrong · BUY · $1,001 - $15,000
  • 2026-03-30 · Alan Armstrong · BUY · $15,001 - $50,000
  • 2024-04-09 · Sheldon Whitehouse · SELL · $1,001 - $15,000
RECENT NEWS
  • How Abogen went from COVID hype to a $7.8B Novartis deal
  • NVS: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
  • Novartis wins FDA approval for Rhapsido as first symptomatic dermographism treatment
  • Novartis advances multiple sclerosis innovation with late-breaking remibrutinib and broad portfolio data at MSToronto2026
  • Notable healthcare headlines for the week: Pfizer, Sanofi, and Novartis in focus
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
NOVARTIS AG (NVS) · Stock Price, Congress Trades, Institutional Holdings · CatalystPit